BG vs. CTVA
BG (Bunge Limited) and CTVA (Corteva, Inc.) are both stocks. BG operates in Farm Products (Consumer Defensive), while CTVA operates in Agricultural Inputs (Basic Materials). Over the past 5 years, BG returned 10.31%/yr vs 12.09%/yr for CTVA. At a 0.43 correlation, their price movements are largely independent.
Performance
BG vs. CTVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BG achieves a 43.64% return, which is significantly higher than CTVA's 15.44% return.
BG
- 1D
- -2.29%
- 1M
- 0.93%
- YTD
- 43.64%
- 6M
- 36.66%
- 1Y
- 76.06%
- 3Y*
- 14.28%
- 5Y*
- 10.31%
- 10Y*
- 9.78%
CTVA
- 1D
- -0.56%
- 1M
- -5.58%
- YTD
- 15.44%
- 6M
- 17.24%
- 1Y
- 9.24%
- 3Y*
- 11.38%
- 5Y*
- 12.09%
- 10Y*
- —
BG vs. CTVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BG Bunge Limited | 43.64% | 18.56% | -20.74% | 3.79% | 9.28% | 46.77% | 18.92% | 15.94% |
CTVA Corteva, Inc. | 15.44% | 18.89% | 20.24% | -17.51% | 25.58% | 23.55% | 33.49% | 2.91% |
Correlation
The correlation between BG and CTVA is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since May 28, 2019 | 0.43 |
Fundamentals
BG:
$24.79B
CTVA:
$51.89B
BG:
$4.12
CTVA:
$1.72
BG:
30.69
CTVA:
44.89
BG:
0.26
CTVA:
2.92
BG:
1.42
CTVA:
2.13
BG:
$80.55B
CTVA:
$17.89B
BG:
$3.58B
CTVA:
$6.00B
BG:
$2.19B
CTVA:
$2.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BG vs. CTVA — Risk / Return Rank
BG
CTVA
BG vs. CTVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bunge Limited (BG) and Corteva, Inc. (CTVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BG | CTVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.04 | ||
| Sortino ratioReturn per unit of downside risk | +2.91 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.09 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 4.97 | 0.45 | +4.52 |
| Martin ratioReturn relative to average drawdown | 13.87 | 0.98 | +12.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BG | CTVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.44 | 0.40 | +2.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | 0.45 | -0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.50 | -0.17 |
Drawdowns
BG vs. CTVA - Drawdown Comparison
The maximum BG drawdown since its inception was -77.34%, which is greater than CTVA's maximum drawdown of -34.76%. Use the drawdown chart below to compare losses from any high point for BG and CTVA.
Loading charts...
Drawdown Indicators
| BG | CTVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.34% | -34.76% | -42.58% |
Max Drawdown (1Y)Largest decline over 1 year | -15.39% | -20.71% | +5.32% |
Max Drawdown (3Y)Largest decline over 3 years | -38.82% | -25.41% | -13.41% |
Max Drawdown (5Y)Largest decline over 5 years | -41.49% | -34.76% | -6.73% |
Max Drawdown (10Y)Largest decline over 10 years | -60.49% | — | — |
Current DrawdownCurrent decline from peak | -3.77% | -9.66% | +5.89% |
Average DrawdownAverage peak-to-trough decline | -28.90% | -10.51% | -18.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.50% | 9.47% | -3.97% |
Volatility
BG vs. CTVA - Volatility Comparison
Bunge Limited (BG) has a higher volatility of 8.35% compared to Corteva, Inc. (CTVA) at 6.81%. This indicates that BG's price experiences larger fluctuations and is considered to be riskier than CTVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BG | CTVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.35% | 6.81% | +1.54% |
Volatility (6M)Calculated over the trailing 6-month period | 19.45% | 15.41% | +4.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.33% | 23.15% | +8.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.27% | 26.90% | +2.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.00% | 32.67% | -1.67% |
Dividends
BG vs. CTVA - Dividend Comparison
BG's dividend yield for the trailing twelve months is around 2.23%, more than CTVA's 0.93% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BG Bunge Limited | 2.23% | 3.12% | 3.48% | 2.55% | 2.31% | 2.76% | 3.05% | 3.48% | 3.59% | 2.62% | 2.21% | 2.11% |
CTVA Corteva, Inc. | 0.93% | 1.04% | 1.16% | 1.29% | 0.99% | 1.14% | 1.34% | 0.88% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BG vs. CTVA - Financials Comparison
This section allows you to compare key financial metrics between Bunge Limited and Corteva, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BG vs. CTVA - Profitability Comparison
BG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bunge Limited reported a gross profit of 766.00M and revenue of 21.86B. Therefore, the gross margin over that period was 3.5%.
CTVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corteva, Inc. reported a gross profit of 0.00 and revenue of 4.91B. Therefore, the gross margin over that period was 0.0%.
BG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bunge Limited reported an operating income of 235.00M and revenue of 21.86B, resulting in an operating margin of 1.1%.
CTVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corteva, Inc. reported an operating income of 725.00M and revenue of 4.91B, resulting in an operating margin of 14.8%.
BG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bunge Limited reported a net income of 68.00M and revenue of 21.86B, resulting in a net margin of 0.3%.
CTVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corteva, Inc. reported a net income of 720.00M and revenue of 4.91B, resulting in a net margin of 14.7%.
Frequently Asked Questions
BG and CTVA have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BG has higher volatility (8.35%) compared to CTVA (6.81%). In terms of maximum drawdown, BG dropped -77.34% vs CTVA's -34.76%.
BG currently has the higher Sharpe Ratio (2.44 vs 0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BG and CTVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer